Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related models

  • Louise Hedskog
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
  • Catarina Moreira Pinho
    Department of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden;
  • Riccardo Filadi
    Department of Biomedical Sciences, University of Padua, 35121 Padua, Italy;
  • Annica Rönnbäck
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
  • Laura Hertwig
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
  • Birgitta Wiehager
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
  • Pia Larssen
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
  • Sandra Gellhaar
    Department of Neuroscience, Karolinska Institutet, 171 65 Stockholm, Sweden; and
  • Anna Sandebring
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
  • Marie Westerlund
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
  • Caroline Graff
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
  • Bengt Winblad
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
  • Dagmar Galter
    Department of Neuroscience, Karolinska Institutet, 171 65 Stockholm, Sweden; and
  • Homira Behbahani
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;
  • Paola Pizzo
    Department of Biomedical Sciences, University of Padua, 35121 Padua, Italy;
  • Elzbieta Glaser
    Department of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden;
  • Maria Ankarcrona
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Alzheimer’s Disease Research Center, Karolinska Institutet, 141 86 Stockholm, Sweden;

書誌事項

公開日
2013-04-25
DOI
  • 10.1073/pnas.1300677110
公開者
Proceedings of the National Academy of Sciences

この論文をさがす

説明

<jats:p> It is well-established that subcompartments of endoplasmic reticulum (ER) are in physical contact with the mitochondria. These lipid raft-like regions of ER are referred to as mitochondria-associated ER membranes (MAMs), and they play an important role in, for example, lipid synthesis, calcium homeostasis, and apoptotic signaling. Perturbation of MAM function has previously been suggested in Alzheimer’s disease (AD) as shown in fibroblasts from AD patients and a neuroblastoma cell line containing familial presenilin-2 AD mutation. The effect of AD pathogenesis on the ER–mitochondria interplay in the brain has so far remained unknown. Here, we studied ER–mitochondria contacts in human AD brain and related AD mouse and neuronal cell models. We found uniform distribution of MAM in neurons. Phosphofurin acidic cluster sorting protein-2 and σ1 receptor, two MAM-associated proteins, were shown to be essential for neuronal survival, because siRNA knockdown resulted in degeneration. Up-regulated MAM-associated proteins were found in the AD brain and amyloid precursor protein (APP) <jats:sub>Swe</jats:sub> <jats:sub>/Lon</jats:sub> mouse model, in which up-regulation was observed before the appearance of plaques. By studying an ER–mitochondria bridging complex, inositol-1,4,5-triphosphate receptor–voltage-dependent anion channel, we revealed that nanomolar concentrations of amyloid β-peptide increased inositol-1,4,5-triphosphate receptor and voltage-dependent anion channel protein expression and elevated the number of ER–mitochondria contact points and mitochondrial calcium concentrations. Our data suggest an important role of ER–mitochondria contacts and cross-talk in AD pathology. </jats:p>

収録刊行物

被引用文献 (14)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ